Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Operating Expenses | 1,053 | 1,206 | 891 | 1,192 | 1,983 |
| Operating Income | -1,053 | -1,210 | -891 | -1,192 | -1,988 |
| Interest Expense | 156 | 70 | 47 | 6 | 4 |
| Other Income | 54 | 3,504 | 75 | -440 | 13 |
| Pre-tax Income | -1,154 | 2,224 | -864 | -1,637 | -1,980 |
| Net Income Continuous | -1,154 | 2,224 | -864 | -1,637 | -1,980 |
| Net Income | $-1,154 | $2,224 | $-864 | $-1,637 | $-1,980 |
| EPS Basic Total Ops | -29.81 | 59.63 | -23.19 | -43.06 | -36.44 |
| EPS Basic Continuous Ops | -29.73 | 59.63 | -23.36 | -44.28 | -39.48 |
| EPS Diluted Total Ops | -16.56 | 46.38 | -23.19 | -43.06 | -36.44 |
| EPS Diluted Continuous Ops | -14.15 | 44.06 | -23.36 | -44.28 | -39.48 |
| EBITDA(a) | $-935 | $-1,088 | $-795 | $-1,134 | $-1,924 |